Literature DB >> 4124155

Histamine release induced by himan leukocyte lysates: implication of a specific, complement-independent, noncytotoxic reaction.

M T Kelly, A White.   

Abstract

The characteristics of histamine release induced by human leukocyte lysates were determined. Intact human leukocytes released histamine during incubation with leukocyte lysates. Maximal release occurred under physiological conditions of temperature and pH, and both Ca(2+) and Mg(2+) were required. The addition of ethylenediaminetetraacetic acid abruptly inhibited release. Complement was not required, and serum actually inhibited release. Histamine release was maximal at lysate concentrations of 0.25 to 1.0 mug of protein per ml, and it was reduced at either higher or lower concentrations. Leukocytes continued to exclude trypan blue and maintained chemotactic activity after histamine release. Leukocytes released histamine independently of cellular protein or enzymes. Histamine release induced by leukocyte lysates was interrupted by subsequent removal of the lysate. The data suggest that this histamine release occurs by a specific, complement-independent, noncytotoxic process which resembles, but is not identical with, antigen-induced histamine release. The system has several unique characteristics which suggest that it is a novel form of inflammatory histamine release. This system should provide a useful in vitro model for studies of cellular processes in human inflammation.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4124155      PMCID: PMC422801          DOI: 10.1128/iai.8.1.8-14.1973

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  13 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Increased vascular permeability produced by human platelet granule cationic extract.

Authors:  R L Nachman; B Weksler; B Ferris
Journal:  J Clin Invest       Date:  1970-02       Impact factor: 14.808

3.  The immediate allergic response: in vitro separation of antigen activation, decay and histamine release.

Authors:  L M Lichtenstein
Journal:  J Immunol       Date:  1971-10       Impact factor: 5.422

4.  Mediators of histamine release from human platelets, lymphocytes, and granulocytes.

Authors:  M T Kelly; R R Martin; A White
Journal:  J Clin Invest       Date:  1971-05       Impact factor: 14.808

5.  Mediators of inflammation in leukocyte lysosomes. VII. Observations on mast cell-rupturing agents in different species.

Authors:  J Scherer; A Janoff
Journal:  Lab Invest       Date:  1968-02       Impact factor: 5.662

6.  Mechanisms of release of constituents from rabbit platelets by antigen-antibody complexes and complement. I. Lytic and nonlytic reactions.

Authors:  P M Henson
Journal:  J Immunol       Date:  1970-08       Impact factor: 5.422

7.  Mechanism of histamine release from mast cells by cationic protein (band 2) from neutrophil lysosomes.

Authors:  N S Ranadive; C G Cochrane
Journal:  J Immunol       Date:  1971-02       Impact factor: 5.422

8.  Reversal of chemotaxis in vitro and chemotactic activity of leukocyte fractions.

Authors:  H P Cornely
Journal:  Proc Soc Exp Biol Med       Date:  1966-07

9.  Histamine release in the dog after leukocyte lysate injection.

Authors:  M T Kelly; R E Brashear; R R Martin; A White
Journal:  Infect Immun       Date:  1971-09       Impact factor: 3.441

10.  The isolation and properties of the specific cytoplasmic granules of rabbit polymorphonuclear leucocytes.

Authors:  Z A COHN; J G HIRSCH
Journal:  J Exp Med       Date:  1960-12-01       Impact factor: 14.307

View more
  2 in total

1.  An inhibitor of histamine release from human leukocytes.

Authors:  M T Kelly; A White
Journal:  J Clin Invest       Date:  1974-05       Impact factor: 14.808

2.  Histamine release induced by human leukocyte lysates: effect of metabolic inhibitors and carbohydrates.

Authors:  M T Kelly; A White
Journal:  Infect Immun       Date:  1973-07       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.